The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment-Reference-Cited by-同舟云学术

The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment

Published:2020-02-05 Issue:9 Volume:35 Page:1590-1594
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Poustchi Hossein¹^ORCID,Majd Jabbari Sara¹,Merat Shahin¹^ORCID,Sharifi Amir‐Houshang¹,Shayesteh Ali Akbar²,Shayesteh Elahe²,Minakari Mohammad³,Fattahi Mohammad Reza⁴,Moini Maryam⁴,Roozbeh Fatemeh⁵,Mansour‐Ghanaei Fariborz⁶,Afshar Behrooz⁷,Mokhtare Marjan⁸,Amiriani Taghi⁹,Sofian Masoomeh¹⁰,Somi Mohammad‐Hossein¹¹,Agah Shahram⁸,Maleki Iradj¹²,Latifnia Maryam¹³,Fattahi Abdizadeh Mojtaba¹⁴,Hormati Ahmad¹⁵¹⁶^ORCID,Khoshnia Masoud¹⁹,Sohrabi Masoudreza¹⁶,Malekzadeh Zeinab¹,Merat Dorsa¹,Malekzadeh Reza¹

Affiliation:

1. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute Tehran University of Medical Sciences Tehran Iran

2. Alimentary Tract Research Center Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

3. Department of Gastroenterology and Hepatology Isfahan University of Medical Sciences Isfahan Iran

4. Gastroenterohepatology Research Center Shiraz University of Medical Sciences Shiraz Iran

5. Department of Gastroenterology and Hepatology Mazandaran University of Medical Sciences Sari Iran

6. Gastrointestinal and Liver Diseases Research Center Guilan University of Medical Sciences Rasht Iran

7. Department of Gastroenterology and Hepatology Hamadan University of Medical Sciences Hamadan Iran

8. Colorectal Research Center Iran University of Medical Sciences Tehran Iran

9. Golestan Research Center for Gastroenterology and Hepatology Golestan University of Medical Science Gorgan Iran

10. Infectious Disease Research Center Arak University of Medical Science Arak Iran

11. Department of Gastroenterology and Hepatology Tabriz University of Medical Sciences Tabriz Iran

12. Gut and Liver Research Center Mazandaran University of Medical Sciences Sari Iran

13. Department of Gastroenterology and Hepatology Sabzevar University of Medical Sciences Sabzevar Iran

14. Cellular and Molecular Research Center Sabzevar University of Medical Sciences Sabzevar Iran

15. Gastroenterology and Hepatology Disease Research Center Qom University of Medical Science Qom Iran

16. Gastrointestinal and Liver Disease Research Center Iran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14994

Reference27 articles.

1. Hepatitis C virus infection in end-stage renal disease and kidney transplantation

2. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS

3. Risk of death among chronic dialysis patients infected with hepatitis C virus

4. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis

5. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies;Journal of Viral Hepatitis;2024-06-03

2. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

3. Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-06-04

4. Rescue use of pegylated interferon in dialysis patient who failed to respond sofosbuvir;Indian Journal of Nephrology;2023

5. The ameliorating role of sofosbuvir and daclatasvir on thioacetamide-induced kidney injury in adult albino rats;Anatomy & Cell Biology;2022-12-22